Potentiation of Osteogenesis and Angiogenesis In Vivo after Implantation of Hydroxyapatite Combined with Autogenous Growth Factors

Abstract

Objective: Growth factors accelerate healing by stimulating matrix production and potentiating angiogenesis. In order to determine whether analogous effects of growth factors can be observed during the early phase of fracture healing, the use of hydroxyapatite (HA) combined with autogenous growth factors was investigated in the present study. For the acquisition of autogenous growth factors the platelet-rich plasma fraction was separated from blood by means of centrifugation.
Design: For the experimental procedure two cylindrical defects were created within the intercondylar region of pig femoral condyles. The proximal defect was filled with HA, the distal with HA enriched with growth factors. Ten and twenty days after surgery the specimens were examined immunohistochemically and ultrastructurally. In order to study angio- and osteogenesis, antibodies to factor VIII, ED-A and, ED-B fibronectin, and to α smooth muscle actin were used.
Results: Even after ten days there was a distinct increase of neovascularisation due to the application of growth factors as demonstrated with factor VIII and ED-B fibronectin antibodies. Moreover, granulation tissue formation was accelerated. After ten days intense labelling for α smooth muscle actin and ED-A fibronectin was observed only in combination with growth factors. Due to the effects of growth factors there is activation of fibroblasts to synthesise the ED-A fibronectin necessary for the induction of myofibroblasts by growth factors. Additionally, a few ED-B positive areas of woven bone including osteoblasts were identified ultrastructurally within the defect area after ten days of local treatment with growth factors. Moreover, the cells responsible for the accelerated degradation of the implant enriched with growth factors were identified ultrastructurally.
Conclusion: Platelet growth factors added to biodegradable hydroxyapatite stimulate angio- and osteogenesis during bone defect healing.

Osteogenesis - angiogenesis - hydroxyapatite - platelet growth factors

References

• 1 Ashcroft G S, Yang X, Glick A B, Weinstein M, Letterio J L, Mizel D E, Anzano M. et al . Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response.  Nature Cell Biol. 1999;  5 260-266
• 2 Balza E, Borsi L, Allemanni G, Zardi L. Transforming growth factor β regulates the level of different fibronectin isoforms in normal human cultured fibroblasts.  FEBS Lett. 1988;  228 42-44
• 3 Beck L S, Amento E P, Xu Y, Deguzman L, Lee W P, Nguyen T, Gillet N A. TGF-beta 1 induces bone closure of skull defects: temporal dynamics of bone formation in defects to rhTGF-beta 1.  J Bone Mineral Res. 1993;  8 753-761
• 4 Berndt A, Borsi L, Luo X, Zardi L, Katenkamp D, Kosmehl H. Evidence of ED-B⁺ fibronectin synthesis in human tissues by non-radioactive RNA in situ hybridization. Investigations on carcinoma (oral squamous cell and breast carcinoma), chronic inflammation (rheumatoid synovitis) and fibromatosis (Morbus Dupuytren).  Histochem Cell Biol. 1998;  109 249-255
• 5 Borsi L, Castellani P, Risso A, Leprini M, Zardi L. Transforming growth factor β regulates the splicing pattern of fibronectin messenger precursor.  FEBS Lett. 1990;  261 175-178
• 6 Burstein F D. Bone substitutes.  Cleft Palate Craniofac J. 2000;  37 1-4
• 7 Dodds R A, Merry K, Littlewood A, Gowen M. Expression of mRNA for IL1-β, IL6, and TGF-β1 in developing human bone and cartilage.  J Histochem Cytochem. 1994;  42 733-744
• 8 Glowacki J. Angiogenesis in fracture repair.  Clin Orthop. 1998;  355 82-89
• 9 Jarnagin W R, Rockey D C, Koteliansky V E, Wang S S, Bissell D M. Expression of variant of fibronectins in wound healing: cellular source and biological activity of the EIIA segment in rat hepatic fibrogenesis.  J Cell Biol. 1994;  127 2037-2048
• 10 Joyce M E, Jingushi S, Bolander M E. Transforming growth factor-beta in the regulation of fracture repair.  Orthop Clin North Am. 1990;  21 199-209
• 11 Liao F, Gotwals P J, Koteliansky V E, Sheppard D, Van De Water L. The EIIIA segment of fibronectin is a ligand for integrins α9β1 and α4β1 providing a novel mechanism for regulating cell adhesion by alternative splicing.  J Biol Chem. 2002;  277 14 467-14 474
• 12 Lind M, Schumacker B, Soballe K, Keller J, Melsen F, Bunger C. Transforming growth factor-beta enhances fracture healing in rabbit tibiae.  Acta Orthop Scand. 1993;  64 553-556
• 13 Nakagawa M, Kaneda T, Arakawa T, Morita S, Sato T, Yomada T, Hanada K. et al . Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts.  FEBS Lett. 2000;  473 161-164
• 14 Probst S. Cellular mechanisms of bone repair.  J Invest Surg. 1997;  10 77-86
• 15 Serini G, Bochaton-Piallat M L, Ropraz P, Geinoz A, Borsi L, Zardi L, Gabbiani G. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1.  J Cell Biol. 1998;  142 873-881
• 16 Zellin G. Growth factors and bone regeneration. Implications of barrier membranes.  Swed Dent J Suppl. 1998;  129 7-65